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Effects of HEPA Air Cleaners on Unscheduled Asthma
Visits and Asthma Symptoms for Children Exposed to
Secondhand Tobacco Smoke
WHAT’S KNOWN ON THIS SUBJECT: Exposure to secondhand
smoke (SHS) is associated with asthma exacerbations in
children. Anticipatory guidance has failed to reduce SHS in
controlled trials. It is not known whether high-efficiency, particle-
arresting (HEPA) air cleaners can reduce SHS or improve asthma
symptoms in children.
WHAT THIS STUDY ADDS: HEPA air cleaners led to reductions in
unscheduled asthma visits and fine airborne particle levels but
not asthma symptoms or cotinine levels. HEPA air cleaners may
be useful as part of a multifaceted strategy to reduce asthma
morbidity among children.
abstract
OBJECTIVE: The goal was to test the effects of high-efficiency, particulate-
arresting (HEPA) air cleaners on unscheduled asthma visits and symp-
toms among children with asthma exposed to secondhand smoke.
METHODS: Weenrolled225eligiblechildrenwhowere6 to12yearsofage,
had physician-diagnosed asthma, and were exposed to5 cigarettes per
day. We conducted a double-blind, randomized trial. Children were as-
signed randomly to receive 2 active or inactive HEPA air cleaners.
RESULTS: Of 225 enrolled children, 110 (49%) were assigned to the
intervention group and 115 (51%) to the control group; 215 (95%)
completed the trial. During the trial, there were 42 fewer unscheduled
asthma visits among children in the intervention group (18.5% [95%
confidence interval: 1.25%–82.75%]; P .043), compared with those in
the control group, after adjustment for baseline differences. Therewas
a significant difference in the reductions of levels of particles of0.3
m according to group assignment; there was a 25% reduction in
particle levels in the intervention group, comparedwith a 5% reduction
in the control group (P .026). Therewere no significant differences in
parent-reported asthma symptoms, exhaled nitric-oxide levels, air nic-
otine levels, or cotinine levels according to group assignment.
CONCLUSIONS: These results hold promise for using HEPA air cleaners
as part of a multifaceted strategy to reduce asthma morbidity, but
further research is necessary before they can be recommended rou-
tinely for the medical management of asthma. Pediatrics 2011;127:93–
101
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Exposure to secondhand smoke (SHS)
is associated with wheezing and
asthma exacerbations in children.1–7
Children who are exposed to SHS are
1.5 times more likely to have
physician-diagnosed asthma orwheez-
ing than are unexposed children,
which accounts for 130 000 excess
cases of asthma among US children.3,7
The mechanism for asthma exacerba-
tions resulting from SHS is not clear,
but cigarette smoke is the major
source of airborne particles in house-
holds with smokers.8 Indeed, concen-
trations of airborne particles of 2.5
m are 2 to 3 times higher in house-
holds with smokers than in house-
holds without smokers.8–10 More than
20% of US children are exposed to
household SHS.11
Numerous studies have tested the effi-
cacy of anticipatory guidance to re-
duce SHS exposure for children, but
the majority failed to show significant
reductions in children’s SHS exposure
by using measurements of cotinine, a
metabolite of nicotine, or improve-
ments in asthma symptoms.12–23 This
problem might be overcome if there
was a technology to reduce SHS
exposure passively, such as high-
efficiency, particulate-arresting (HEPA)
air cleaners.
There are limited data on the efficacy
of HEPA air cleaners in reducing
asthma symptoms. More than 10 trials
have tested the effects of HEPA air
cleaners, but the largest involved 45
subjects; only 2 studied children exclu-
sively.24,25 None of those trials tested
HEPA air cleaners among SHS-exposed
children with asthma, but HEPA air
cleaners can reduce levels of airborne
particles and nicotine.26,27 Reisman et
al26 reported a 73% reduction in the
level of airborne particles of0.3 m
with HEPA air cleaners. Bascom et al27
reported 50% reductions in levels of
airborne particles and nicotine. Other
trials incorporated HEPA air cleaners
to reduce environmental triggers
among children with asthma, but it
was not possible to quantify the spe-
cific contribution of the air cleaners
because the studies involved multiple
environmental interventions.28,29 We
speculated that children with asthma
who were exposed to SHS would par-
ticularly benefit by using air cleaners.
The purpose of this double-blind, ran-
domized trial was to test the efficacy of
HEPA air cleaners in reducing un-
scheduled asthma visits, asthma




The Cincinnati Asthma Prevention
Study was a randomized, double-blind
trial to test the effects of HEPA air
cleaners, in the homes of 225 SHS-
exposed children with physician-
diagnosed asthma, on unscheduled
asthma visits and symptoms. Families
assigned to the intervention group re-
ceived 2 active HEPA air cleaners (Aus-
tin Healthmate [Buffalo, NY]), that is,
HEPA air cleaners surrounded by a car-
bon-potassium permanganate-zeolite
insert, whereas families in the control
group received 2 inactive (placebo) air
cleaners. For both groups, 1 air
cleaner was installed in themain activ-
ity room and the other was installed in
the child’s bedroom at the baseline
home visit. The air cleaners were
equipped with monitors to measure
the number of hours they operated.
There were no attempts to reduce to-
bacco use or other asthma triggers.
HEPA air cleaners are certified to re-
move 99% of airborne particles of
0.3 m in a 1500-ft2 room. The
carbon-potassium permanganate-
zeolite filter insert was designed to ab-
sorb odors and gases. The inactive air
cleaners, which were indistinguish-
able from the active HEPA air cleaners,
contained 3 layers of prefilter cloth (a
blend of cotton and polyester fibers),
which also were present in the active
air cleaners. At the end of the trial, we
offered to install HEPA filters in the air
cleaners for families assigned to re-
ceive inactive air cleaners during the
trial.
The Cincinnati Children’s Hospital Med-
ical Center institutional review board
approved this study. Parents or legal
guardians provided written consent
before enrollment.
Study Participants
We screened children and their fami-
lies for eligibility from May 31, 2001,
through March 27, 2003, by using a
sampling frame of children who had
received treatment for asthma at a
clinic, emergency department, or hos-
pital affiliated with Cincinnati Chil-
dren’s Hospital Medical Center or
Group Health Associates. Initially, we
mailed letters to families. Potential
participants were able to decline any
further involvement or telephone con-
tact by returning a prepaid postcard
or by telephoning our research coordi-
nators. If the family did not decline par-
ticipation within 10 days, then a re-
search coordinator contacted the
family to describe the study, to deter-
mine eligibility, and, if the family was
eligible, to invite the members to par-
ticipate in the trial.
Children were eligible if they were 6 to
12 years of age at enrollment, had
physician-diagnosed asthma in the
previous 12 months, according to In-
ternational Classification of Diseases,
Ninth Revision, billing codes (from hos-
pital records, emergency department
visit records, or primary care physi-
cian records), experienced1 exacer-
bation requiring an unscheduled visit
in the past year, were exposed to the
smoke of5 cigarettes per day in and
around the house, and lived within a
9-county area surrounding Cincinnati.
Children were excluded if they were al-
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ready using an air cleaner, if their
home lacked electricity, if they had co-
existing medical problems (eg, mental
retardation, congenital heart disease,
or cystic fibrosis), or if their family
planned to move in the next year.
Random Assignment
Children were assigned randomly to
receive active HEPA air cleaners or in-
active air cleaners. Allocation conceal-
ment was performed by using opaque
envelopes, which were opened by a re-
search assistant immediately before
the baseline home visit was con-
ducted. With the exception of the serial
numbers, the active and inactive HEPA
air cleaners were indistinguishable.
All of the investigators, research staff
members, and participants were
masked to group assignment until the
end of the trial, except for the biostatisti-
cian (Dr Hornung), who was responsible
for randompermutation of the air clean-
ers by using serial numbers.
Outcome Measures
We conducted extensive surveys at
baseline to characterize the children,
their families, and the home environ-
ment. Research assistants surveyed
the children’s parent or guardian at
baseline and at 3-month intervals
about unscheduled asthma visits,
asthma symptoms, therapy, and to-
bacco exposure. Our primary outcome
measure was asthma exacerbation,
defined as any unscheduled visit to a
health care provider (clinic visit, emer-
gency visit, or hospitalization). We se-
lected unscheduled asthma visits as
our primary outcomemeasure a priori
because it was the most-objective
measure of asthma exacerbation. We
estimated that, to detect a 20% reduc-
tion in unscheduled visits attributable
to asthma exacerbations with 80%
power, we would require a sample size
of 110 children per group, or a total of
220 children (  .05, 2-tailed test).
This calculation assumed that we
would have a rate of attrition of10%.
Secondary outcome measures in-
cluded asthma symptoms assessed
with the Child Health Asthma Survey
(an instrument shown to be reliable,
internally consistent, and able to dis-
tinguish levels of asthma severity30,31),
tobacco smoke exposure, indoor air-
borne particle levels, and exhaled
nitric-oxide levels.
Air nicotine levels, which provide an
objective measure of ambient tobacco
smoke exposure, were measured in
each subject’s home by using nicotine
dosimeters.32–34 For standardization,
the dosimeters were housed in ametal
compartment on the air cleaner that
was located in the main activity room.
Dosimeters were placed at the base-
line and 6-month visits and were re-
trieved at the 6- and 12-month visits,
respectively. The dosimeters, which
have a limit of detection of 0.01 g per
filter, were analyzed by using a stan-
dardized protocol.32–34
To test the efficacy of the HEPA air
cleaners in reducing children’s SHS ex-
posure, wemeasured cotinine levels in
children’s serum and hair at baseline
and at 6 and 12 months.35 Serum sam-
ples were analyzed at the National Cen-
ter for Environmental Health, Centers
for Disease Control and Prevention (At-
lanta, GA), by using high-performance
liquid chromatography linked to atmo-
spheric pressure chemical ionization/
tandem mass spectrometry.36 The de-
tection limit for cotinine in serum was
0.05 ng/mL. We collected 20 strands of
hair from the occipital region of the
scalp. The hair samples were analyzed
for cotinine at the Hospital for Sick
Children (Toronto, Ontario, Canada), by
using a radioimmunoassay.37 The de-
tection limit for cotinine in hair was
0.005 ng/mg.37
To test the effect of the HEPA air clean-
ers on airborne particles, we used a
GT-321 particle counter (Met One In-
struments, Grant Pass, OR) tomeasure
concentrations of indoor particles
(particles per cubic foot) at the base-
line and 6- and 12-month visits. We took
measurements of the numbers of air-
borne particles of 0.3 m and 5
m; each reading was the average of
ten 6-second measurements taken
over 1minute in 3 different locations in
each housing unit. The data used in the
analysis are the mean of 3 readings
from themain activity room, the child’s
bedroom, and the kitchen, taken at the
beginning of each home visit.
We assessed nitric-oxide levels in ex-
haled air at the baseline and 6- and
12-month visits. Exhaled air was col-
lected in Mylar balloons from each
participant by using a validated offline
technique to assess the effect of HEPA
air cleaners on airway inflamma-
tion.38,39 A model 280i nitric-oxide ana-
lyzer (Sievers Instruments, Boulder,
CO) was used for nitric-oxide analysis.
As described previously, exhaled
nitric-oxide concentrations were im-
puted when the exhaled nitric-oxide
analysis did not occur within 24 hours
after collection.40
Serum samples were obtained at the
baseline visit by a trained pediatric
phlebotomist, for determination of
allergen-specific immunoglobulin E by
using the ImmunoCap test (Pharmacia
Diagnostics, Portage, MI). Children
with class I or higher immunoglobulin
E levels (0.35 kU/L) for dust mite,
dog, cat, or cockroach allergen were
considered to have atopy.
Statistical Analyses
We calculated descriptive statistics
according to group assignment. For
continuous variables, we calculated
means, SDs, and ranges. For categori-
cal variables, we calculated frequen-
cies and proportions. All analyses
were performed according to the in-
tention to treat. For continuous vari-
ables, we usedmultivariate regression
analyses for either the untransformed
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or logarithmically transformed out-
come, as appropriate. For repeated-
measures analyses over the 12months
of the study, we used mixed-effects lin-
ear models with an autoregressive co-
variance structure. The interaction of
group assignment and timewas tested
as the primary hypothesis of an inter-
vention effect. When the outcome was
a rate or count (eg, unscheduled
asthma visits), the generalized esti-
mating equation version of Poisson re-
gression was used for repeated mea-
sures, in a manner similar to the
mixed-effects linear model. In second-
ary a priori analyses, we tested the ef-
ficacy of the HEPA air cleaners for fam-
ilies who used either HEPA air cleaner
for 6130 hours (ie, 70% of the
entire trial).
RESULTS
Of the 2240 children in the sampling
frame who were 6 to 12 years of age,
had physician-diagnosed asthma ac-
cording to International Classification
of Diseases, Ninth Revision, billing
codes, and resided in a 9-county area
surrounding Cincinnati, we screened
1694 (76%) for eligibility between May
31, 2001, and March 27, 2003. Of these
children, 353 (21%) were eligible to
participate (Fig 1). Of the 353 eligible
children and their families, 225 (64%)
agreed to participate in the trial.
There were no significant differ-
ences in children’s age, gender,
asthma severity, or race, parents’
education, marital status, household
income, or health insurance, or num-
ber of cigarettes smoked in or
around the house per day for fami-
lies that chose to participate versus
those that chose not to participate.
Of the 225 families that agreed to par-
ticipate, 110 (49%) were assigned ran-
domly to the intervention group and
115 (51%) to the control group. At
baseline, the mean age of the children
was 8.6 years (range: 5.3–11.7 years);
62% of the children were male. Chil-
dren were exposed to a geometric
mean of 13 cigarettes per day. Num-
bers of unscheduled asthma visits and
airborne particle levels were signifi-
cantly greater in the control group.
Some other measures of asthma se-
verity tended to be greater in the con-
trol group, but these differences were
not statistically significant (Tables 1
and 2). Of the 225 children enrolled in
the trial, 215 (95%) completed the
study (Fig 1).
In unadjusted analyses, there were
fewer unscheduled asthma visits at
follow-up assessment in the interven-
tion group (189 vs 274 visits; P .046).
This difference persisted after adjust-
ment for baseline differences in the
multivariate analyses. With adjust-
ment for baseline differences, there
was a significant difference in the rate
of decrease in the number of unsched-
uled asthma visits among children in
the intervention group, compared with
the control group (Fig 2). The adjusted
FIGURE 1
Enrollment, random assignment, and retention of Cincinnati Asthma Prevention study participants.
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mean number of unscheduled visits
for the intervention group decreased
by 8.9% per month, compared with a
decrease of 0.9% per month in the con-
trol group. With adjustment for base-
line differences, there were 185 un-
scheduled asthma visits among
children in the intervention group,
compared with 227 unscheduled
asthma visits among children in the
control group, a reduction of 42 visits
(95% confidence interval: 1.25–82.75
visits; P .043). This is equivalent to a
reduction of 18.5% (95% confidence in-
terval: 1%–36%) in the number of un-
scheduled asthma visits during the
study (Table 3).
In a secondary analysis, developed a
priori, we examined the effect of HEPA
air cleaners among 141 (68%) of 207
families with functioning monitors
who used 1 or both air cleaners70%
of the time. With adjustment for base-
line differences in unscheduled
asthma visits, the rate of reduction in
the number of unscheduled asthma
visits over time was significantly
greater in the intervention group, com-
pared with the control group (P 
.006). The number of unscheduled
asthma visits for the intervention
group decreased by 12.7% per month,
comparedwith an increase of 0.7% per
month in the control group.
There was a significant difference in
the reductions in the numbers of air-
borne particles of0.3 m according
to group assignment (P .026) (Table
4). The absolute mean reduction in lev-
els of airborne particles of 0.3 m
during the trial was 1.1 106 particles
per ft3 for the intervention group,
which was equivalent to a 25% reduc-
tion in airborne particle levels. In con-
trast, there was a reduction of only
0.3 106 particles per ft3 (5%) for the
control group. There was no signifi-
cant difference in levels of airborne
particles of5maccording to group
assignment (Table 4).
There were no significant differences
between groups with respect to sever-
ity of asthma symptoms, medication
use, exhaled nitric-oxide levels, air nic-
otine levels, serum cotinine levels, or
hair cotinine levels during the trial (Ta-
ble 3). Therewere no significant group-
season (P .328) or group-allergy se-
verity (P  .583) interactions for
unscheduled asthma visits.
To validate parents’ reports of un-
scheduled visits, we examined the rate







Age, mean SD, y 8.8 1.8 8.4 1.8 .160
Male, n (%) 74 (67) 65 (57) .097
Race, n (%) .565
Black 65 (59) 60 (52) —
White 43 (39) 52 (45) —
Other 2 (2) 3 (3) —
Annual household income, mean SD, $ 30 524 24 416 29 595 21 649 .767
No. of unscheduled asthma visits in previous
3 mo, mean SD
0.6 1.0 1.0 1.4 .013
Measures of asthma severity, n (%)
Allergy severity (moderate to very severe) 47 (43) 55 (48) .443
Shortness of breath (moderate to very severe) 46 (42) 61 (53) .104
Tightness in chest (moderate to very severe) 29 (27) 37 (33) .317
Wheeze (moderate to very severe) 44 (40) 46 (40) .955
Difficulty sleeping (moderate to very severe) 42 (38) 53 (46) .208
Steroid therapy in previous 3 mo 30 (27) 37 (34) .305
Long-acting steroid therapy 58 (53) 60 (52) .877
Duration of asthma, mean SD, d 9.8 18.7 10.2 11.7 .841
Serum immunoglobulin E levels of0.35 kU/L for
common allergens, n (%)
74 (67) 70 (61) .310
Exhaled nitric-oxide level, mean SD, ppb 14.7 10.0 16.3 12.3 .302
TABLE 2 Baseline Exposure to Environmental Tobacco Smoke and Indoor Airborne Particles







No. of cigarettes smoked around house
per d, mean SD
12.9 1.8 13.3 2.2 .716
Serum cotinine level, mean SD, ng/mL 1.18 3.9 1.23 3.3 .622
Hair cotinine level, mean SD, ng/mg 0.14 3.8 0.14 3.5 .970
No. of airborne particles, mean SD, 106/ft3
Particles of0.3 m 4.0 2.56 4.7 2.58 .003




























Mean numbers of unscheduled asthma visits in
the previous 3 months, reported at quarterly
intervals during the trial, according to group
assignment, with adjustment for differences in
the numbers of unscheduled asthma visits at
baseline. The solid line and closed circles indi-
cate the intervention group; dashed line and
open circles, control group.
ARTICLES
PEDIATRICS Volume 127, Number 1, January 2011 97
of agreement of parent-reported un-
scheduled asthma visits by using med-
ical billing records from the Cincinnati
Children’s Hospital Medical Center. We
found that 87% of parent-reported un-
scheduled asthma visits (714 of 824
visits) were in agreement with billing
records for each 3-month interval.
DISCUSSION
We found, in a randomized, double-
blind trial, that HEPA air cleaners led to
an 18.5% reduction in unscheduled
asthma visits. The differences in un-
scheduled asthma visits were appar-
ent only at 9 and 12 months. We also
found a significant difference in the re-
duction of levels of airborne particles
of0.3 m in the intervention group,
compared with the control group. In
contrast, there were not significant re-
ductions in levels of the gaseous phase
of SHS exposure, asthma symptoms, or
exhaled nitric oxide. These data sug-
gested that HEPA air cleaners reduced
unscheduled asthma visits for chil-
dren by reducing exposure to airborne
particles of 0.3 m but without a
corresponding reduction in the gas-
eous phase of tobacco smoke.
Although these results are somewhat
paradoxical, our results are consistent
with other controlled trials of environ-
mental interventions. In a multifaceted
trial to reduce indoor pollutants that
included portable HEPA air cleaners,
Morgan et al28 reported a 13.6% reduc-
tion in the number of unscheduled vis-
its attributable to asthma and a signif-
icant reduction in asthma symptoms.
In a trial of multiple environmental in-
terventions that included HEPA air
cleaners, Eggleston et al29 reported a
significant improvement in asthma
symptoms but no difference in un-
scheduled asthma visits according to
group assignment. In a trial to reduce
exposures to indoor asthma triggers
among inner-city children that did not
include portable air cleaners, Krieger
et al41 reported a 15% reduction in un-
scheduled asthma visits but no signifi-
cant improvement in asthma symp-
toms. It is not clear whether the
differences across these studies are
attributable to the type or intensity of
TABLE 3 Numbers of Unscheduled Asthma Visits, Asthma Symptoms, Reported Exposure to
Tobacco Smoke, and Exhaled Nitric-Oxide Levels According to Group Assignment
Characteristics 3 mo 6 mo 9 mo 12 mo P
No. of unscheduled asthma visits in previous 3 mo, mean .043a
Intervention group (n 110) 0.7 0.5 0.4 0.3
Control group (n 115) 0.6 0.5 0.9 0.6
Moderate/severe allergy in previous 3 mo, % .618
Intervention group (n 110) 35 32 40 33
Control group (n 115) 38 40 34 34
In previous 2 wk, how much of time haschild’s name
had
Shortness of breath (some, most, or all of time), % .415
Intervention group (n 110) 34 28 29 19
Control group (n 115) 36 27 24 28
Tightness in chest (some, most, or all of time), % .612
Intervention group (n 110) 22 16 18 14
Control group (n 115) 22 10 16 17
Wheeze (some, most, or all of time), % .168
Intervention group (n 110) 32 15 22 13
Control group (n 115) 25 20 15 19
Difficulty sleeping (some, most, or all of time), % .299
Intervention group (n 110) 26 21 27 21
Control group (n 115) 27 18 16 18
Prescription for steroid therapy in previous 3 mo, % .811
Intervention group (n 110) 19 13 16 19
Control group (n 115) 27 25 18 27
Prescription for long-acting steroid therapy in previous
3 mo, %
.135
Intervention group (n 110) 36 43 42 39
Control group (n 115) 46 39 30 37
No. of episodes of asthma, mean .294
Intervention group (n 110) 8.9 4.3 6.5 4.5
Control group (n 115) 9.3 6.0 6.3 6.8
Exhaled nitric-oxide level, mean, ppb .313
Intervention group (n 110) — 16.4 — 16.1
Control group (n 115) — 15.0 — 16.8
No. of cigarettes smoked around house per d, mean .977
Intervention group (n 110) 7.5 11.2 7.5 9.5
Control group (n 115) 7.5 10.6 7.1 9.5
a Test of group difference in trends over time (group-time interaction), adjusted for differences in the number of baseline visits.
TABLE 4 Exposures to Tobacco and Indoor Particles, According to Group Assignment, During Study
Characteristic Baseline 6 mo 12 mo P
Serum cotinine level, mean, ng/mL .738
Intervention group (n 110) 1.1 1.1 1.1
Control group (n 115) 1.2 1.1 1.0
Hair cotinine level, mean, ng/mg .984
Intervention group (n 110) 0.1 0.12 0.15
Control group (n 115) 0.1 0.11 0.15
Air nicotine level, g .191
Intervention group (n 110) — 3.1 2.5
Control group (n 115) — 2.5 2.7
No. of particles of0.3 m, mean SD, 106/ft3 .026a
Intervention group (n 110) 4.0 2.5 3.0
Control group (n 115) 4.7 4.6 4.4
No. of particles of5 m, mean SD, 106/ft3 .219a
Intervention group (n 110) 0.0033 0.0029 0.0027
Control group (n 115) 0.0037 0.0028 0.0024
a Test of differences in group means, including baseline particle levels.
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the environmental intervention, sam-
ple size, or eligibility criteria. Collec-
tively, however, these trials provide
evidence that environmental interven-
tions can reduce asthma morbidity in
children.42
Results of studies that have exam-
ined the contribution of SHS expo-
sure to asthma exacerbations in chil-
dren 3 years of age have been
inconsistent. Several studies found
that SHS was associated with asthma
exacerbations or bronchial hyperac-
tivity in older children, whereas oth-
ers did not.3,6,7,43,44 The vast majority
of studies relied on parents’ reports
of smoking behavior to quantify the
risk of asthma, wheezing, or dimin-
ished pulmonary functions associ-
ated with SHS exposure; fewer stud-
ies used objective biomarkers such
as cotinine levels.7,43,44 Although we
found a significant reduction in the
number of unscheduled asthma vis-
its among children, there was not a
corresponding reduction in the gas-
eous phase of tobacco smoke, as as-
sessed with objective measures of
air nicotine levels and biomarkers of
internal doses. In contrast, there
was a reduction in the levels of fine
indoor particles, the predominant
size generated by tobacco smoke.
Therefore, this study provides some
evidence that airborne particles
from SHS or other pollutants repre-
sent a risk factor for asthma exacer-
bations in children.
More than 10 trials have tested the
efficacy of anticipatory guidance re-
garding children’s exposure to to-
bacco smoke, by using cotinine as an
objective biomarker of exposure.12–23
Only from 1 of those studies was a sus-
tained reduction in exposure to envi-
ronmental tobacco smoke, measured
as cotinine levels, reported, and from
another study a significant reduction
in the number of unscheduled asthma
visits was reported.12,13 Collectively,
these trials raise serious questions
about whether it is prudent to continue
to rely on anticipatory guidance to re-
duce children’s exposure to tobacco
smoke. Our failure to show a reduction
in the gaseous phase of children’s ex-
posure to SHS by using a passive envi-
ronmental intervention provides addi-
tional support for regulations to ban
smoking in public places and residen-
tial settings to reduce children’s expo-
sure to tobacco smoke.
There are some limitations of this
study. First, our primary outcome
measure, that is, numbers of un-
scheduled asthma visits, and air-
borne particle levels were not
equally distributed in our 2 treat-
ment arms at baseline; although the
decreases in the number of unsched-
uled asthma visits and levels of air-
borne particles of 0.3 m re-
mained statistically significant after
adjustment for baseline differences,
this suggests that the 2 groups were
not equivalent. Second, we examined
many relevant end points and our
primary result, that the air cleaners
led to a significant reduction in the
number of unscheduled asthma vis-
its, might have been spurious. This is
unlikely, however, because we ob-
served a larger effect among the
families who used the air cleaners
consistently. Third, use of a different
HEPA air cleaner might have led to
different results. Fourth, we used
only 2 HEPA air cleaners in each
housing unit. A portable HEPA air
cleaner is certified to clean 1
average-sized room and not an en-
tire house. Fifth, the air nicotine do-
simeters, which were placed on the
HEPA air cleaners in the main activity
rooms, might not have provided rep-
resentative measurements of house-
hold exposure. Finally, by focusing on
older children, who are less vulnera-
ble to SHS exposure,7,43,44 we might
have decreased our chances of showing
an effect of HEPA air cleaners.
CONCLUSIONS
Our ultimate goal should be to elimi-
nate tobacco use and SHS exposure
for children. Despite efforts to re-
duce exposure,20% of US children
are exposed to SHS in their homes.11
Moreover, air quality in housing of-
ten is inadequate.10 Therefore, it is
critical to identify ways to reduce ex-
posure to SHS and other pollutants,
especially for children with asthma.
We found that HEPA air cleaners led
to significant reductions in numbers
of unscheduled asthma visits and
levels of fine airborne pollutants but
not in parent-reported asthma symp-
toms, cotinine levels, or exhaled
nitric-oxide levels. These results hold
promise for using HEPA air cleaners
as part of a multifaceted strategy to
reduce asthma morbidity, but they
also emphasize the importance of
finding ways to reduce the sources of
exposure further.
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MISTAKES IN THE HOSPITAL: Patients are taken to the hospital to get better.
Unfortunately, hospitalization carries with it a significant risk for adverse
events. As reported on NewYorkTimes.com (November 16, 2010:1–3), one of
every seven hospitalized Medicare beneficiaries is harmed as a result of the
medical care received. The report on patient safety from the Inspector General
for the Department of Health and Human Services is based on an exhaustive
review of a representative sample of 780 patient files. The report estimates that
in October 2008 alone, approximately 134,000 hospitalized Medicare beneficia-
ries experienced at least one adverse event. Events ranged from mild and tem-
porary to severe and permanent including death. Almost 44% of these events
were likely preventable. Medication errors leading to such problems as exces-
sive bleeding were the most frequent adverse event. Poor patient management,
e.g. leading to fluid overload was also common. Hospital acquired infections
continue to be a major issue. Extremely infrequent are problems that should
never happen under any condition such as performing surgery on the wrong
patient. While physicians and hospitals have designed systems to help prevent
errors, errors continue to happen at a distressing rate. The report recommends
not only to broaden the definitions of error and harm in the hospital but to give
hospitals financial incentives to reduce errors. While pediatricians infrequently
take care of Medicare patients, the report emphasizes that we all need to be
mindful of a cardinal rule in medicine: first, do no harm.
Noted by WVR, MD
ARTICLES
PEDIATRICS Volume 127, Number 1, January 2011 101
